# Chemed Corp: Form 10-Q for the period ended Sep 30, 2013

- Company: [Chemed Corp](/companies/che.md) (CIK 19584)
- Form: 10-Q
- Filed: 2013-11-01
- Accepted by EDGAR: Nov 1, 2013, 08:22 ET
- Period: 2013-09-30
- Accession: 0001157523-13-005200
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/19584/000115752313005200/a50738518.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/19584/000115752313005200/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-07-01 to 2013-09-30 | $340.9m | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2013-01-01 to 2013-09-30 | $1.06bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2013-07-01 to 2013-09-30 | $243.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2013-01-01 to 2013-09-30 | $762.9m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2013-07-01 to 2013-09-30 | $48.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2013-01-01 to 2013-09-30 | $157.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-07-01 to 2013-09-30 | $29.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2013-01-01 to 2013-09-30 | $94.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2013-07-01 to 2013-09-30 | $3.5m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2013-01-01 to 2013-09-30 | $11.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2013-07-01 to 2013-09-30 | $8.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2013-01-01 to 2013-09-30 | $31.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-07-01 to 2013-09-30 | $17.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2013-01-01 to 2013-09-30 | $54.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.94 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2013-01-01 to 2013-09-30 | $2.89 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.96 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2013-01-01 to 2013-09-30 | $2.95 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-07-01 to 2013-09-30 | 18,522,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2013-01-01 to 2013-09-30 | 18,824,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2013-01-01 to 2013-09-30 | $135.9m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2013-01-01 to 2013-09-30 | $18.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2013-01-01 to 2013-09-30 | $10.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2013-01-01 to 2013-09-30 | $89.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2013-09-30 | $83.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-09-30 | $216.4m | us-gaap:AssetsCurrent |
| Total assets | at 2013-09-30 | $881.5m | us-gaap:Assets |
| Current liabilities | at 2013-09-30 | $376.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-09-30 | $454.7m | us-gaap:Liabilities |
| Current portion of debt | at 2013-09-30 | $181.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2013-09-30 | $426.8m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2013-09-30 | 17,634,176 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/19584/000115752313005200/a50738518.htm

Filed Nov 1, 2013.
Source: SEC EDGAR, the filing index for accession 0001157523-13-005200. Last ingested by Listed: Nov 14, 2026, 12:29 ET. No prices; not investment advice.
